17 papers
Allergy and immunology explores how our bodies recognize threats and defend against them, covering everything from seasonal sneezes to complex immune system disorders. This field sits at the intersection of how we react to harmless substances and how our defenses malfunction, affecting millions of people worldwide. Understanding these mechanisms is crucial for developing better treatments and vaccines that keep us safe from both common irritants and serious diseases.
On Gist.Science, we bring you the very latest research directly from medRxiv, ensuring you never miss a breakthrough as it happens. We process every new preprint in this category as soon as it is posted, offering both accessible plain-language summaries and detailed technical breakdowns. This dual approach allows researchers, clinicians, and curious readers to grasp the core findings without getting lost in dense jargon while still having access to the full scientific rigor.
Below are the latest papers in allergy and immunology, updated daily with fresh insights from the global scientific community.
This study identifies treatment-specific circulating microRNAs in children that predict longitudinal asthma control and distinguish between budesonide and placebo responses, highlighting their potential as molecular markers for monitoring disease progression and therapeutic efficacy.
This study of 670 Kenyan children across three vaccine trials found that pre-vaccination vitamin B12 deficiency and anaemia were associated with reduced pneumococcal vaccine immunogenicity, suggesting that optimizing nutritional status could improve vaccine responses in populations with common micronutrient deficiencies.
This systematic review and meta-analysis of 79 studies synthesizes evidence that severe dengue arises from an integrated pathogen-host injury syndrome involving viral burden, cytokine amplification, and endothelial dysfunction, concluding that while combined biomarker panels show high predictive potential, they require further prospective external validation before routine clinical deployment.
This study demonstrates that adult-onset type 1 diabetes is frequently preceded by a progressive, multi-decade emergence of islet autoantibodies, with 85% of patients showing seropositivity years before clinical diagnosis, thereby highlighting a significant window for early risk stratification and preventive intervention.
This study of the Rotterdam Study cohort identifies age, sex, smoking status, BMI, season, and corticosteroid use as key determinants of total and inhaled allergen-specific IgE levels in middle-aged and elderly adults, suggesting that accounting for these factors can improve the clinical interpretation of IgE for allergic conditions.
This study demonstrates that implementing a standardized Human Phenotype Ontology (HPO) framework with clinician training enables high-quality, granular phenotypic data capture in a large UK CVID cohort, successfully linking specific immune profiles and genetic variants to distinct clinical subgroups to advance genotype-phenotype understanding and therapeutic strategies.
This study establishes a genetically driven immunologic mechanism linking Epstein-Barr virus to multiple sclerosis by identifying shared genetic risk loci and demonstrating that EBV-infected memory B cells alter differentiation and upregulate cytokines and risk genes to modulate T cell activation.
This study utilizes multiparameter immunophenotyping of 207 participants to demonstrate that while both ME/CFS and long COVID present with overlapping clinical features, they are driven by distinct immunopathological mechanisms characterized by immune exhaustion in long COVID versus immune suppression in ME/CFS.
This study identifies distinct clonal signatures in T cell receptors associated with antithyroid drug-induced agranulocytosis, revealing that HLA-B*38:02 and HLA-DRB1*08:03 risk alleles drive disease pathogenesis through specific expansions of CD8+ effector memory and CD4+ central memory T cell clones, respectively.
This multi-cohort transcriptomic analysis of 150 Systemic Lupus Erythematosus patients demonstrates that the strength of the Type I interferon signature significantly correlates with alloimmunization-associated gene expression programs, suggesting IFN-I activity as a potential biomarker for transfusion-related alloimmunization susceptibility in SLE.